Skip to main content
SpringerLink
Log in
Book cover

Sepsis pp 78–86Cite as

Randomized Controlled Trials in Sepsis

  • Chapter

  • 2343 Accesses

Part of the book series: Competency-Based Critical Care ((CBCC))

During the past two decades, there has been a great increase in our understanding of the patho-physiology of sepsis and septic shock. This has revealed numerous potential therapeutic targets and major advances in cell and molecular biology have enabled basic scientists to synthesize a large array of new compounds and agents with a potential role in the treatment of sepsis. Using the approach outlined in Table 12.1, this chapter discusses the research basis of major clinical trials in sepsis, the evidence base for sepsis management, and highlights major issues that require further background work and clinical trials to resolve.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abraham E. Tissue factor inhibition and clinical trial results of tissue factor pathway inhibitor in sepsis. Crit Care Med 2000;28(suppl 9):S31–S33.

    Article  PubMed  CAS  Google Scholar 

  • Abraham E, et al. Lenercept in severe sepsis and early septic shock. Crit Care Med 2001;29:503–510.

    Article  PubMed  CAS  Google Scholar 

  • Abraham E, Laterre PF, Garg R, et al. Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death. N Engl J Med 2005;353:1332–1341.

    Article  PubMed  CAS  Google Scholar 

  • Abraham E, Reinhart K, Opal S, Demeyer I, et al. Effi -cacy and safety of Tifacogin (recombinant Tissue factor pathway inhibitor) in severe sepsis. JAMA 2003;290:238–247.

    Article  PubMed  CAS  Google Scholar 

  • Angus DC, Latterre PF, Helterbrand J, et al. The effect of doltrecogin alfa (activated) on long-term survival after severe sepsis. Crit Care Med 2004;32:2199–2206.

    Article  PubMed  CAS  Google Scholar 

  • Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005;365:63–78.

    Article  PubMed  CAS  Google Scholar 

  • Annane D, Sebille V, Charpentier C, Bollaert PE, et al. Effect of treatment with low dose hydrocortisone and fl udrocortisone on mortality in patients with septic shock. JAMA 2002;288:862–871.

    Article  PubMed  CAS  Google Scholar 

  • Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr. Effi cacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344(10):699–709.

    Article  PubMed  CAS  Google Scholar 

  • Cochrane Injures Group Albumin Reviewers. Human albumin administration in critically ill patients: systemic review of randomized controlled trials. BMJ 1998;317:235–240.

    Google Scholar 

  • Cronin L, Cook DJ, Carlet J, et al. Corticosteroids treatment for sepsis: a critical appraisal and metaanalysis of the literature. Crit Care Med 1995;23:1430–1439.

    Article  PubMed  CAS  Google Scholar 

  • Cross AS. Antiendotoxin antibodies. Ann Int Med 1994;121:58–60.

    PubMed  CAS  Google Scholar 

  • Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004;30:536–555.

    Article  PubMed  Google Scholar 

  • Eisele B, Lamy M, Thijs LG, et al. Anti-thrombin III in patients with severe sepsis. Intensive Care Med 1998;24:663–672.

    Article  PubMed  CAS  Google Scholar 

  • Fisher CJ, Agosti JM, Opal SM, Lowry SF, et al. Treatment of septic shock with tumour necrosis factor receptor:Fc fusion protein. N Eng J Med 1996;344:1697–1702.

    Article  Google Scholar 

  • Gattinoni L, Brazzi L, Pelosi P, et al. A trial of goal-orientated hemodynamic therapy in critically ill patients. N Engl J Med 1995;333:1025–1032.

    Article  PubMed  CAS  Google Scholar 

  • Grootendorst AF, van Bommel EFH, van der Hoven B. High volume hemaofi ltration improves hemodynam-ics of endotoxin-induced shock in the pig. J Crit Care 1992;7:67–75.

    Article  Google Scholar 

  • Hamrahian AH, Oseni TS, Arafah BM. Measurements of serum free cortisol in critically ill patients. N Engl J Med 2004;350:1629–1638.

    Article  PubMed  CAS  Google Scholar 

  • Hinds CJ. Treatment of sepsis with activated protein C. BMJ 2001;323:881–882.

    Article  PubMed  CAS  Google Scholar 

  • Holmes CL, Patel BM, Russel JA, Walley KR. Physiology of vasopressin relevant to management of septic shock. Chest 2001;120:989–1002.

    Article  PubMed  CAS  Google Scholar 

  • Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003;348:138–150.

    Article  PubMed  CAS  Google Scholar 

  • Landry DW, Levin HR, Gallant EM, et al. Vasopressin defi ciency contributes to vasodilation of septic shock. Circulation 1997;95:1122–1125.

    PubMed  CAS  Google Scholar 

  • Malay MB, Ashton RC, Landry DW, et al. Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 1999;47:699–703.

    Article  PubMed  CAS  Google Scholar 

  • Malmberg K, Norhammar A, Wedel H, Ryden L. Glyco-metabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: longterm results from the Diabetes and Insulin-Glucose infusion in Acute Myocardial Infarction study (DIGAMI). Circulation 1999;99:2626–2632.

    PubMed  CAS  Google Scholar 

  • McCloskey RV, Straube RC, Sanders C, Smith S, et al. Treatment of septic shock with human monoclonal antibody HA-1A. Ann Int Med 1994;121:1–5.

    PubMed  CAS  Google Scholar 

  • Mullner M, Uranek B, Havel C, et al. Vasopressors for shock. The Cochrane database of systematic reviews 2004, Issue 3. Art. No: CD003709.pub2. DOI: 1002/ 14651858.CD003709.pub2.

    Google Scholar 

  • NICE Guideline—www.nice.org. TA084 Sepsis (severe)— drotrecogin—Guidance.

  • Reinhart K, et al. for the AFELIMOMAB Sepsis Study Group. Randomized-placebo-controlled trial of the anti-tumour necrosis factor antibody fragment Afelimomab in hyperinfl ammatory response during severe sepsis: RAMES Study. Crit Care Med 2001; 29:765–769.

    Article  PubMed  CAS  Google Scholar 

  • Reiter K, Bellomo R, Ronco C, Kellum J. Pro/con clinical debate: Is high-volume haemofi ltration benefi cial in the treatment of septic shock? Crit Care 2002; 6(1);18–21.

    Article  PubMed  Google Scholar 

  • Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368–1377.

    Article  PubMed  CAS  Google Scholar 

  • Roberts I, Alderson P, Bunn F, et al. Colloids versus crystalloids for fl uid resuscitation in critically ill patients. The Cochrane Database of Systemic Reviews 2004, Issue 4. Art No.:CD000567.pub2.DOI: 10.1002/14651858.CD000567.pub2.

    Google Scholar 

  • Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G. Effects of different doses in continuous veno-venous haemofi ltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000;356:26–30.

    Article  PubMed  CAS  Google Scholar 

  • The Safe Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care. N Engl J Med 2004;350:2247–2256.

    Article  Google Scholar 

  • Van de Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359–1367.

    Article  PubMed  Google Scholar 

  • Warren BL, Eid A, Singer P, Pillay SS, et al. High dose Antithrombin III in severe sepsis. JAMA 2001; 286:1869–1878.

    Article  PubMed  CAS  Google Scholar 

  • Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Eng J Med 1999;340:207–214.

    Article  CAS  Google Scholar 

  • Wheeler AP, Doig C, Wright T, et al. Baseline characteristics and survival of adult severe sepsis patients treated with drotrecogin alfa (activated) in a global, single-arm, open-label trial (ENHANCE). Chest 2003; 124:91S, abstract.

    Google Scholar 

  • Wilson J, Woods I, Fawcett J, et al. Reducing the risk of major elective surgery: randomised controlled trial of preoperative optimisation of oxygen delivery. BMJ 318:1099–1103.

    Google Scholar 

  • Wright SE, Bodenham A, Short AIK, Turney JH. The provision and practice of renal replacement therapy on adult intensive care units in the United Kingdom. Anaesthesia 2003;58(11):1063–1069.

    Article  PubMed  CAS  Google Scholar 

  • Yan SB, Helterband JD, Hartman DL, et al. Low levels of protein C are associated with poor outcome in severe sepsis. Chest 2001;120:915–922.

    Article  PubMed  CAS  Google Scholar 

  • Zeigler EJ, Fisher CJ, Sprung CL, Straube RC, et al. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. New Eng J Med 1991;324:429–436.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Royal Victoria Infirmary Newcastle-upon-Tyre, Department of Anaesthesia, UK

    Helen J. Curtis MBBS, FRCP & Anna Harmar MBBS

Authors
  1. Helen J. Curtis MBBS, FRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anna Harmar MBBS
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. European Diploma in ITU Royal Victoria Infirmary, University of Newcastle-upon-Tyne Newcastle-upon-Tyne, UK

    Simon V. Baudouin MBBS, MD, FRCP

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag London Limited

About this chapter

Cite this chapter

Curtis, H.J., Harmar, A. (2008). Randomized Controlled Trials in Sepsis. In: Baudouin, S.V. (eds) Sepsis. Competency-Based Critical Care. Springer, London. https://doi.org/10.1007/978-1-84628-939-2_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-939-2_12

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-938-5

  • Online ISBN: 978-1-84628-939-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation